DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

XenoPort, Inc.


4.20 0.02 (0.48%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

XNPT $4.20 0.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.16
Previous Close $4.18
Daily Range $4.03 - $4.27
52-Week Range $3.89 - $7.59
Market Cap $252.0M
P/E Ratio -2.31
Dividend (Yield) $0.00 (0.0%)
Volume 405,338
Average Daily Volume 469,221
Current FY EPS -$1.38





XenoPort, Inc. (XNPT) Description

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs. Website:

News & Commentary

Xenoport's Path Is Long, But The Potential Is There

XenoPort Enters Oversold Territory (XNPT)

Short Interest Makes 17.8% Move For XNPT

XenoPort's 4Q Loss Narrower-Than-Expected - Analyst Blog

XenoPort's 4Q Loss Narrower-Than-Expected - Analyst Blog

XenoPort's CEO Discusses Q4 2013 Results - Earnings Call Transcript

XenoPort, Inc. Discusses Q4 2013 Results (Webcast)

Can a New Indication for Lyrica Help Results at Pfizer?

A new study showed the efficacy of using Lyrica to treat Restless Legs Syndrome over another treatment -- Boehringer Ingelheim’s Mirapex.

Investors Are Coming Back Around On XenoPort

US Stock Futures Tumble; All Eyes On P&G, Honeywell Earnings

XenoPort Prices 12M Share Offering at $6.00/Share

See More XNPT News...

XNPT's Top Competitors

XNPT $4.20 (0.48%)
Current stock: XNPT
JNJ $98.96 (0.21%)
Current stock: JNJ
NVS $84.67 (0.31%)
Current stock: NVS
RHHBY $36.22 (0.14%)
Current stock: RHHBY